Drawing for CUREVO

USPTO serial 79221428

CUREVO

Reviewed by CopyMark Law Group

Reg. 5619567Status 706Registered
Filing date
Status date
Registration date
Dec 4, 2018
Examiner
BILLINGS, JOHN T
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with CUREVO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brendan J. Hughes

Brendan J. Hughes Cooley LLP1299 Pennsylvania Avenue, NW, Suite 700Washington, DC 20004United States

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical agents affecting sensory organs; Thyroid and para-thyroid hormone preparations; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for treating diabetes; Pharmaceutical agents affecting metabolism; Vaccines against flu; veterinary vaccines; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for regulating the immune system; Virucides; ] Vaccine preparations [ ; Adrenal hormone preparations; Pharmaceutical preparations and substances for use in gynecology; Pharmaceutical preparations for use in urology; Vitamin tablets; Pharmaceutical preparations for wounds; Pharmaceutical preparations for activating cellular function; Anti-inflammatory preparations; Pharmaceutical agents affecting digestive organs; Reagents for use in veterinary genetic testing; Pharmaceutical preparations for the treatment of cardiovascular disease; Ophthalmic preparations; Ophthalmologic preparations; Eye drops; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations and substances for the prevention of cancer; Biological preparations for the treatment of cancer; Pharmaceutical agents for epidermis; Sanitary sterilising preparations; Medicines for the treatment of gastrointestinal diseases; medicated mouth treatment preparations; Parasiticides for medical use; Diagnostic preparations for medical or veterinary purposes; Cleansing solutions for medical use; Cardiovascular agents for medical purposes; Reagents for medical use; Reagents for use in medical genetic testing; Hemostatics for medical purposes; Antibacterial substances for medical purposes; Diuretics; Insulin; Human vaccine preparations; General anesthetics; Pharmaceutical preparations for the treatment of auto-immune diseases; Multivitamin preparations; Pharmaceutical preparations acting on the central nervous system; Styptic pencils; Pharmaceutical preparations for treating asthma; Pharmaceutical solutions used in dialysis; Penicillin preparations; Antimicrobials for dermatologic use; Pharmaceutical preparations for treating skin disorders; Contraceptive preparations; Antihypertensives; Anti-diabetic pharmaceuticals; Antitoxins; Antivirals; Antiarrhythmic agents; Antibiotic preparations; Anti-cancer preparations; Anticoagulants; Tumor suppressing agents; Antifungal preparations; Anti-dermoinfectives; Antidotes; Antipyretic analgesics; Vasoconstrictors; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Mixed antibiotic preparations; Mixed hormone preparations; Chemotherapeutics; Pharmaceutical preparations for use in discouraging the smoking habit ]ACTIVE—
035[ Retail and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; advertising services relating to pharmaceutical products; advertising relating to pharmaceutical products and in-vivo imaging products ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2026INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jul 20, 2026INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Jul 16, 2026INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 16, 2026INPCINVALIDATION PROCESSED—
Dec 26, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 22, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 26, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Apr 26, 202571AGREGISTERED-SEC.71 ACCEPTED—
Apr 21, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 5, 2024ES71TEAS SECTION 71 RECEIVED—
Jun 6, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 6, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 6, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 6, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 6, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 4, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 22, 2023CHLDCHANGE OF OWNER RECEIVED FROM IB—
Apr 5, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 15, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 15, 2019FIMPFINAL DISPOSITION PROCESSED—
Mar 4, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 4, 2018LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Dec 4, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 30, 2018LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Sep 18, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 18, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 15, 2018GPNXNOTIFICATION PROCESSED BY IB—
Aug 29, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 29, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 29, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 10, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 20, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 20, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 20, 2018ALIEASSIGNED TO LIE—
Jul 18, 2018ALIEASSIGNED TO LIE—
Jul 6, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 6, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 6, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 10, 2018RFNTREFUSAL PROCESSED BY IB—
Jan 20, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 20, 2018RFRRREFUSAL PROCESSED BY MPU—
Jan 10, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 9, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 8, 2018DOCKASSIGNED TO EXAMINER—
Dec 9, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 5, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 23, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance